DEVICE CATEGORY · SDL
Transvenous Temporary Phrenic Nerve Stimulator
The device is intended to be implanted transvenously to stimulate the phrenic nerves to improve weaning from a mechanical ventilator. The device is temporary (<30 days) and is for use only in patients 18 years of age or older.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
AeroPace SystemP240012/S008 | Lungpacer Medical USA, Inc. | PMA supplement | Sep 25, 2026 | FDA |
AeroPace SystemP240012 | Lungpacer Medical USA, Inc. | PMA approval | Dec 4, 2024 | FDA |
Source information
Follow the FDA links to view the original records.

